CGON
Price
$26.72
Change
-$1.74 (-6.11%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
2.17B
20 days until earnings call
COGT
Price
$12.49
Change
+$0.29 (+2.38%)
Updated
Jul 18, 04:59 PM (EDT)
Capitalization
1.7B
25 days until earnings call
Interact to see
Advertisement

CGON vs COGT

Header iconCGON vs COGT Comparison
Open Charts CGON vs COGTBanner chart's image
CG Oncology
Price$26.72
Change-$1.74 (-6.11%)
Volume$16.9K
Capitalization2.17B
Cogent Biosciences
Price$12.49
Change+$0.29 (+2.38%)
Volume$46.51K
Capitalization1.7B
CGON vs COGT Comparison Chart in %
Loading...
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CGON vs. COGT commentary
Jul 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CGON is a Hold and COGT is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 18, 2025
Stock price -- (CGON: $28.46 vs. COGT: $12.20)
Brand notoriety: CGON and COGT are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CGON: 156% vs. COGT: 115%
Market capitalization -- CGON: $2.17B vs. COGT: $1.7B
CGON [@Biotechnology] is valued at $2.17B. COGT’s [@Biotechnology] market capitalization is $1.7B. The market cap for tickers in the [@Biotechnology] industry ranges from $299.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CGON’s FA Score shows that 0 FA rating(s) are green whileCOGT’s FA Score has 0 green FA rating(s).

  • CGON’s FA Score: 0 green, 5 red.
  • COGT’s FA Score: 0 green, 5 red.
According to our system of comparison, COGT is a better buy in the long-term than CGON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CGON’s TA Score shows that 5 TA indicator(s) are bullish while COGT’s TA Score has 4 bullish TA indicator(s).

  • CGON’s TA Score: 5 bullish, 2 bearish.
  • COGT’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, CGON is a better buy in the short-term than COGT.

Price Growth

CGON (@Biotechnology) experienced а +4.98% price change this week, while COGT (@Biotechnology) price change was +12.44% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.49%. For the same industry, the average monthly price growth was +13.01%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

CGON is expected to report earnings on Aug 07, 2025.

COGT is expected to report earnings on Nov 17, 2025.

Industries' Descriptions

@Biotechnology (+2.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CGON($2.17B) has a higher market cap than COGT($1.7B). COGT YTD gains are higher at: 56.410 vs. CGON (-0.767). CGON has higher annual earnings (EBITDA): -134.35M vs. COGT (-284.04M). CGON has more cash in the bank: 688M vs. COGT (246M). CGON has less debt than COGT: CGON (1.04M) vs COGT (17.1M). CGON has higher revenues than COGT: CGON (662K) vs COGT (0).
CGONCOGTCGON / COGT
Capitalization2.17B1.7B128%
EBITDA-134.35M-284.04M47%
Gain YTD-0.76756.410-1%
P/E RatioN/AN/A-
Revenue662K0-
Total Cash688M246M280%
Total Debt1.04M17.1M6%
FUNDAMENTALS RATINGS
COGT: Fundamental Ratings
COGT
OUTLOOK RATING
1..100
31
VALUATION
overvalued / fair valued / undervalued
1..100
84
Overvalued
PROFIT vs RISK RATING
1..100
50
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CGONCOGT
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
83%
Declines
ODDS (%)
Bearish Trend 4 days ago
85%
Bearish Trend 24 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
View a ticker or compare two or three
Interact to see
Advertisement
CGON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
COGT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLYCX36.68N/A
N/A
Nuveen Large Cap Select C
RYANX140.28N/A
N/A
Rydex Nova A
OGRIX34.57N/A
N/A
Invesco Comstock Select R6
MWEMX48.68N/A
N/A
MFS Global Equity R6
SBLGX64.37N/A
N/A
ClearBridge Large Cap Growth A

CGON and

Correlation & Price change

A.I.dvisor indicates that over the last year, CGON has been loosely correlated with IDYA. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if CGON jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CGON
1D Price
Change %
CGON100%
+9.13%
IDYA - CGON
62%
Loosely correlated
-0.27%
SYRE - CGON
59%
Loosely correlated
+4.26%
ACLX - CGON
58%
Loosely correlated
+0.35%
KYMR - CGON
57%
Loosely correlated
+1.85%
NUVL - CGON
55%
Loosely correlated
+0.28%
More

COGT and

Correlation & Price change

A.I.dvisor indicates that over the last year, COGT has been loosely correlated with SPHDF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if COGT jumps, then SPHDF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COGT
1D Price
Change %
COGT100%
+2.87%
SPHDF - COGT
63%
Loosely correlated
N/A
ATXS - COGT
52%
Loosely correlated
-1.42%
IDYA - COGT
50%
Loosely correlated
-0.27%
XNCR - COGT
50%
Loosely correlated
+2.72%
CGON - COGT
49%
Loosely correlated
+9.13%
More